Turning Point Therapeutics CEO Athena Countouriotis' 2021 pay rises 11% to $17M
Turning Point Therapeutics reports 2021 executive compensation
By ExecPay News
Published: April 29, 2022
Turning Point Therapeutics reported fiscal year 2021 executive compensation information on April 29, 2022.
In 2021, seven executives at Turning Point Therapeutics received on average a compensation package of $6M, a 12% increase compared to previous year.
Average pay of disclosed executives at Turning Point Therapeutics
Athena Countouriotis, Chief Executive Officer, received $17M in total, which increased by 11% compared to 2020. 58% of Countouriotis' compensation, or $9.8M, was in option awards. Countouriotis also received $508K in non-equity incentive plan, $651K in salary, $6M in stock awards, as well as $37K in other compensation.
Mohammad Hirmand, Chief Medical Officer, received a compensation package of $5.6M, which increased by 713% compared to previous year. 50% of the compensation package, or $2.8M, was in option awards.
Annette North, General Counsel, earned $5.5M in 2021, a 79% increase compared to previous year.
Paolo Tombesi, Chief Financial Officer, received $4.6M in 2021.
Siegfried Reich, P.H.D, Chief Scientific Officer, earned $4M in 2021, a 31% decrease compared to previous year.
Yi Larson, Chief Financial Officer, received $3.9M in 2021, which increases by 72% compared to 2020.
Brian Baker, Former Senior Vice President, Finance and Administration, earned $1.8M in 2021.
Related executives
Paolo Tombesi
Turning Point Therapeutics
Chief Financial Officer
Mohammad Hirmand
Turning Point Therapeutics
Chief Medical Officer
Siegfried PHD
Turning Point Therapeutics
Chief Scientific Officer
Annette North
Turning Point Therapeutics
General Counsel
Yi Larson
Turning Point Therapeutics
Chief Financial Officer
Brian Baker
Turning Point Therapeutics
Former Senior Vice President, Finance and Administration
Athena Countouriotis
Turning Point Therapeutics
Chief Executive Officer
You may also like
Source: SEC filing on April 29, 2022.